JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M403857200 on May 13, 2004

J. Biol. Chem., Vol. 279, Issue 33, 34655-34664, August 13, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/33/34655    most recent
M403857200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toledo, M. S.
Right arrow Articles by Hakomori, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toledo, M. S.
Right arrow Articles by Hakomori, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cell Growth Regulation through GM3-enriched Microdomain (Glycosynapse) in Human Lung Embryonal Fibroblast WI38 and Its Oncogenic Transformant VA13*

Marcos S. Toledo{ddagger}§, Erika Suzuki{ddagger}§, Kazuko Handa{ddagger}, and Senitiroh Hakomori{ddagger}§¶||

From the {ddagger}Pacific Northwest Research Institute, Seattle, Washington 98122-4302 and the Departments of §Pathobiology and Microbiology, University of Washington, Seattle, Washington 98195

Cell growth control mechanisms were studied based on organization of components in glycosphingolipid-enriched microdomain (GEM) in WI38 cells versus their oncogenic transformant VA13 cells. Levels of fibroblast growth factor receptor (FGFR) and cSrc were 4 times and 2–3 times higher, respectively, in VA13 than in WI38 GEM, whereas the level of tetraspanin CD9/CD81 was 3–5 times higher in WI38 than in VA13 GEM. Csk, the physiological inhibitor of cSrc, was present in WI38 but not in VA13 GEM. Functional association of GEM components in control of cell growth in WI38 is indicated by several lines of evidence. (i) Confluent, growth-inhibited WI38 showed a lower degree of FGF-induced MAPK activation than actively growing cells in sparse culture. (ii) The level of inactive cSrc (with Tyr-527 phosphate) was higher in confluent cells than in actively growing cells. Both processes i and ii were inhibited by GM3 since they were enhanced by GM3 depletion with D-threo-1-phenyl-2-palmitoylamino-3-pyrrolidino-1-propanol (P4). (iii) The high level of inactive cSrc associated with growth-inhibited cells was caused by coexisting Csk in WI38 GEM. (iv) Interaction of GM3 with FGFR was demonstrated by binding of GM3 to FGFR in the GEM fraction, as probed with GM3-coated beads, and by confocal microscopy. In contrast to WI38, both cSrc and MAPK in VA13 were strongly activated regardless of FGF stimulation or GM3 depletion by P4. Continuous, constitutive activation of both cSrc and MAPK was due to (i) a much higher level of cSrc and FGFR in VA13 than in WI38 GEM, (ii) their close association/interaction in VA13 GEM as indicated by clear coimmunoprecipitation between cSrc and FGFR, and (iii) the absence of Csk in VA13 GEM, making GEM incapable of inhibiting cSrc activation.


Received for publication, April 7, 2004 , and in revised form, May 12, 2004.

* This work was supported by NCI, National Institutes of Health Grant R01 CA80054 (to S. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Pacific Northwest Research Inst., 720 Broadway, Seattle, WA 98122-4302. E-mail: hakomori{at}u.washington.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
T. Takahashi, K. Murakami, M. Nagakura, H. Kishita, S. Watanabe, K. Honke, K. Ogura, T. Tai, K. Kawasaki, D. Miyamoto, et al.
Sulfatide Is Required for Efficient Replication of Influenza A Virus
J. Virol., June 15, 2008; 82(12): 5940 - 5950.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. R. Todeschini, J. N. Dos Santos, K. Handa, and S.-i. Hakomori
Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway
PNAS, February 12, 2008; 105(6): 1925 - 1930.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. R. Todeschini, J. N. Dos Santos, K. Handa, and S.-i. Hakomori
Ganglioside GM2-Tetraspanin CD82 Complex Inhibits Met and Its Cross-talk with Integrins, Providing a Basis for Control of Cell Motility through Glycosynapse
J. Biol. Chem., March 16, 2007; 282(11): 8123 - 8133.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S.-J. Yoon, K.-i. Nakayama, T. Hikita, K. Handa, and S.-i. Hakomori
Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor
PNAS, December 12, 2006; 103(50): 18987 - 18991.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Wang, Z. Sun, A. V. Li, and K. J. Yarema
Roles for UDP-GlcNAc 2-Epimerase/ManNAc 6-Kinase outside of Sialic Acid Biosynthesis: MODULATION OF SIALYLTRANSFERASE AND BiP EXPRESSION, GM3 AND GD3 BIOSYNTHESIS, PROLIFERATION, AND APOPTOSIS, AND ERK1/2 PHOSPHORYLATION
J. Biol. Chem., September 15, 2006; 281(37): 27016 - 27028.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Mitsuzuka, K. Handa, M. Satoh, Y. Arai, and S. Hakomori
A Specific Microdomain ("Glycosynapse 3") Controls Phenotypic Conversion and Reversion of Bladder Cancer Cells through GM3-mediated Interaction of {alpha}3{beta}1 Integrin with CD9
J. Biol. Chem., October 21, 2005; 280(42): 35545 - 35553.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. S. Toledo, E. Suzuki, K. Handa, and S. Hakomori
Effect of Ganglioside and Tetraspanins in Microdomains on Interaction of Integrins with Fibroblast Growth Factor Receptor
J. Biol. Chem., April 22, 2005; 280(16): 16227 - 16234.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
D. M. Bryant, F. G. Wylie, and J. L. Stow
Regulation of Endocytosis, Nuclear Translocation, and Signaling of Fibroblast Growth Factor Receptor 1 by E-Cadherin
Mol. Biol. Cell, January 1, 2005; 16(1): 14 - 23.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. C. Li, R. T. Worrell, J. B. Matthews, H. Husseinzadeh, L. Neumeier, S. Petrovic, L. Conforti, and M. Soleimani
Identification of a Carboxyl-terminal Motif Essential for the Targeting of Na+-HCO-3 Cotransporter NBC1 to the Basolateral Membrane
J. Biol. Chem., October 8, 2004; 279(41): 43190 - 43197.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.